AI Research Summary
Before Human ReviewBased on abstract · Full text not reviewed
This is a summary based only on the abstract, and the full text was not reviewed. The authors argue that generative AI can help with the creation, management, and traceability of quality documents in clinical development, but that establishing governance is difficult amid changing regulatory guidance. By reviewing regional regulations and guidance, they organize key elements such as transparency, data privacy, validation, and risk management, and propose a documentation methodology that includes RAG, HITL, and lifecycle monitoring.
Key Points from the Abstract
- Presents transparency, privacy, validation, and risk management as the core governance elements of regional regulations and guidance
- Argues that documentation using RAG is useful for improving confidentiality and accuracy
- Emphasizes the need to integrate ethical principles, HITL, and lifecycle monitoring
Relevance to AI Law and Policy
Offers direct implications for the design of generative AI governance, documentation, and regulatory compliance in clinical development.
Limitations to Consider
- Summary based only on the abstract; the full text was not reviewed
- The details of the research design and methods are not sufficiently identifiable from the abstract
- Limitations are not specified in the abstract, so further identification is not possible
Please compare with the original text before citing or using it in your assessment.
Abstract Preview
Generative AI is increasingly applied to design and manage quality management pyramid documents, supporting traceability…Read more in the abstract and original text Research Topic
Original text and source
Generative AI and Clinical Development: Exploring the Frontier of AI Governance Utilizing Generative AI-Conceptual Framework for AI Governance in Clinical Development
The Korean title on this page was translated by AI.- Database
- Crossref